ALS2CR13 polyclonal antibody

ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2) .

9007-83-4

Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.

ALS2CR13; Protein FAM117B; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein

Q6P1L5

Human, Mouse, Rat

KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human ALS2CR13. The exact sequence is proprietary.

Unconjugated

WB

WB (1/500 - 1/1000)

Unmodification

~ 70 kDa

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

For research use only, not for use in diagnostic procedure.

Recognizes endogenous levels of ALS2CR13 protein.

Western blot analysis of ALS2CR13 expression in A549 (A), mouse muscle (B), mouse kidney (C), rat muscle (D) whole cell lysates.

Rabbit